These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 36192029)
21. Leprosy. Recognition and treatment. Ramos-e-Silva M; Rebello PF Am J Clin Dermatol; 2001; 2(4):203-11. PubMed ID: 11705247 [TBL] [Abstract][Full Text] [Related]
22. Leprosy survey in industries in Bombay. Revankar CR; Gupta V; Deshpande SS; Pai R; Ganapati R Indian J Lepr; 1989 Jul; 61(3):367-72. PubMed ID: 2768884 [TBL] [Abstract][Full Text] [Related]
23. Chronic rhinitis: a manifestation of leprosy. Camacho ID; Burdick A; Benjamin L; Casiano R Ear Nose Throat J; 2011 Sep; 90(9):E1-3. PubMed ID: 21938685 [TBL] [Abstract][Full Text] [Related]
24. A study of leprosy in children, from a tertiary pediatric hospital in India. Mahajan S; Sardana K; Bhushan P; Koranne RV; Mendiratta V Lepr Rev; 2006 Jun; 77(2):160-2. PubMed ID: 16895073 [No Abstract] [Full Text] [Related]
26. Occurrence and management of leprosy reaction in China in 2005. Shen J; Liu M; Zhou M; Wengzhong L Lepr Rev; 2009 Jun; 80(2):164-9. PubMed ID: 19743620 [TBL] [Abstract][Full Text] [Related]
27. Necrotic erythema nodosum reaction associated with histological alterations of Lucio's phenomenon. Góes LDM; Morais PM; Rebello PFB; Schettini APM An Bras Dermatol; 2022; 97(2):231-235. PubMed ID: 34996656 [TBL] [Abstract][Full Text] [Related]
28. Fulminant hepatic failure in a 15 year old boy with borderline lepromatous leprosy and type 2 reaction. Mendiratta V; Malik M; Gurtoo A; Chander R Lepr Rev; 2014 Mar; 85(1):54-7. PubMed ID: 24974443 [TBL] [Abstract][Full Text] [Related]
29. Borderline lepromatous leprosy presenting as a single cutaneous plaque. Armour KS; Scolyer RA; Barnetson RS Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652 [TBL] [Abstract][Full Text] [Related]
30. Thyroid functional status in leprosy patients in Sudan. Kheir MM; Ahmed AM; Elsarrag AA East Mediterr Health J; 2001; 7(1-2):79-83. PubMed ID: 12596955 [TBL] [Abstract][Full Text] [Related]
31. Case for diagnosis. Infiltrated areas on the trunk. Góes LDM; Scrignoli JA; Morais P; Talhari C An Bras Dermatol; 2020; 95(5):652-654. PubMed ID: 32651045 [TBL] [Abstract][Full Text] [Related]
32. Borderline lepromatous leprosy. Matsuo C; Talhari C; Nogueira L; Rabelo RF; Santos MN; Talhari S An Bras Dermatol; 2010; 85(6):921-2. PubMed ID: 21308324 [TBL] [Abstract][Full Text] [Related]
33. Leprosy in children: correlation of clinical, histopathological, bacteriological and immunological parameters. Sehgal VN; Joginder Lepr Rev; 1989 Sep; 60(3):202-5. PubMed ID: 2682106 [TBL] [Abstract][Full Text] [Related]
34. Annular vesiculobullous eruptions in type 2 reaction in borderline lepromatous leprosy: a case report. Kar HK; Raina A; Sharma PK; Bhardwaj M Indian J Lepr; 2009; 81(4):205-8. PubMed ID: 20704077 [TBL] [Abstract][Full Text] [Related]
37. Leprosy among inmates of a prison. Vijayakumaran P; Manimozhi N; Ravikumar RN; Jesudasan K; Rao PS Indian J Lepr; 1996; 68(3):247-50. PubMed ID: 8889610 [TBL] [Abstract][Full Text] [Related]
38. Recurrent erythema nodosum leprosum leading to secondary renal amyloidosis and nephrotic syndrome in an Indian patient with lepromatous leprosy. Ahuja R; Garg S; Barwad A; Subbiah A; Gupta V Int J Dermatol; 2023 Sep; 62(9):e514-e517. PubMed ID: 37066445 [No Abstract] [Full Text] [Related]
39. Increased incidence of cytoplasmic ANCA (cANCA) and other autoantibodies in leprosy patients from western India. Pradhan V; Badakere SS; Shankar Kumar U Lepr Rev; 2004 Mar; 75(1):50-6. PubMed ID: 15072126 [TBL] [Abstract][Full Text] [Related]